137 related articles for article (PubMed ID: 29653814)
1. Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence.
Rieken M; Kluth LA; Fajkovic H; Capitanio U; Briganti A; Krabbe LM; Margulis V; Abufaraj M; Mari A; Foerster B; Raman JD; Regelman M; Brookman-May S; Sjoberg DD; Karakiewicz PI; Shariat SF
Clin Genitourin Cancer; 2018 Aug; 16(4):e903-e908. PubMed ID: 29653814
[TBL] [Abstract][Full Text] [Related]
2. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
3. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
[TBL] [Abstract][Full Text] [Related]
4. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
5. Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series.
van der Mijn JC; Al Hussein Al Awamlh B; Islam Khan A; Posada-Calderon L; Oromendia C; Fainberg J; Alshak M; Elahjji R; Pierce H; Taylor B; Gudas LJ; Nanus DM; Molina AM; Del Pizzo J; Scherr DS
PLoS One; 2019; 14(12):e0226285. PubMed ID: 31815952
[TBL] [Abstract][Full Text] [Related]
6. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
7. Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes.
Romeo A; Garcia Marchiñena P; Jurado AM; Gueglio G
Urol Oncol; 2020 Feb; 38(2):42.e7-42.e12. PubMed ID: 31711833
[TBL] [Abstract][Full Text] [Related]
8. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
9. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
[TBL] [Abstract][Full Text] [Related]
10. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
Brookman-May SD; May M; Shariat SF; Novara G; Zigeuner R; Cindolo L; De Cobelli O; De Nunzio C; Pahernik S; Wirth MP; Longo N; Simonato A; Serni S; Siracusano S; Volpe A; Morgia G; Bertini R; Dalpiaz O; Stief C; Ficarra V; ; ;
BJU Int; 2013 Nov; 112(7):909-16. PubMed ID: 23890378
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
[TBL] [Abstract][Full Text] [Related]
12. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
Zhou W; Herwald SE; Uppot RN; Arellano RS
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma: The role of radical surgery on different patterns of local or distant recurrence.
Di Franco G; Palmeri M; Sbrana A; Gianardi D; Furbetta N; Guadagni S; Bianchini M; Stefanini G; Adamo G; Pollina LE; Galli L; Di Candio G; Morelli L
Surg Oncol; 2020 Dec; 35():106-113. PubMed ID: 32866943
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.
Yohannan J; Feng T; Berkowitz J; Connolly SS; Pierorazio P; Allaf ME
J Endourol; 2010 Oct; 24(10):1609-12. PubMed ID: 20629564
[TBL] [Abstract][Full Text] [Related]
15. Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma.
Eggener SE; Yossepowitch O; Kundu S; Motzer RJ; Russo P
J Urol; 2008 Sep; 180(3):873-8; discussion 878. PubMed ID: 18635225
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
17. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
[TBL] [Abstract][Full Text] [Related]
18. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
19. Patterns and Predictors of Recurrence after Partial Nephrectomy for Kidney Tumors.
Mouracade P; Kara O; Maurice MJ; Dagenais J; Malkoc E; Nelson RJ; Kaouk JH
J Urol; 2017 Jun; 197(6):1403-1409. PubMed ID: 27993666
[TBL] [Abstract][Full Text] [Related]
20. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
